InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+24.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by SOBECKI CHRISTOPHER J, Director. Director active across 4 companies, notably WW INTERNATIONAL, INC.. Aggregated, 17 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €120k. History available since 5 July 2021. The latest transaction was filed on 13 May 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations17 total
36,810 shares0Common StockSEC:0001127602-25-014144:0
8,032 shares0Common StockSEC:0001127602-24-013557:0
1,353 shares0Common StockSEC:0001209191-23-033104:0
9,302 shares0Common StockSEC:0001127602-23-016437:0
5,067 shares0Common StockSEC:0001209191-23-000960:0
30,000 shares@ US$4.1708100.0% of flowCommon StockSEC:0001209191-22-058099:0
Ideal exit: 14 Aug 2023 (T+270)
4,595 shares0Common StockSEC:0001209191-22-052843:0
2,745 shares0Common StockSEC:0001209191-22-041165:0
4,024 shares0Common StockSEC:0001127602-22-012833:0
1,797 shares0Common StockSEC:0001209191-22-023472:0
1,179 shares@ US$15.9017.0% of flowCommon StockSEC:0001209191-22-001665
1,179 shares@ US$15.900.015% mcap17.0% of flowCommon StockSEC:0001209191-22-001665:0
998 shares@ US$18.780.015% mcap16.7% of flowCommon StockSEC:0001209191-21-059828:0
998 shares@ US$18.7816.7% of flowCommon StockSEC:0001209191-21-059828
523 shares@ US$35.840.015% mcap16.3% of flowCommon StockSEC:0001209191-21-045811:0
523 shares@ US$35.8416.3% of flowCommon StockSEC:0001209191-21-045811
462 sharesCommon StockSEC:0001209191-16-090045:0
17 of 17 declarations
About SOBECKI CHRISTOPHER J
Sobecki Christopher J is a Director at WW International, Inc. and Lexicon Pharmaceuticals, Inc. In this role, he oversees the activities of these companies and participates in strategic decision-making. Christopher is committed to promoting transparency and ensuring that shareholder interests are considered in all decisions.
